LDS/Medical Tests/Pseudocholinesterase, Dibucaine Inhibition

Pseudocholinesterase, Dibucaine Inhibition

Pseudocholinesterase (butyrylcholinesterase, BCHE) is a serine hydrolase enzyme synthesized in the liver and present in plasma. It hydrolyzes ester-containing drugs such as succinylcholine and mivacurium, which are neuromuscular blocking agents used in anesthesia. Unlike acetylcholinesterase, which is concentrated at neuromuscular junctions, pseudocholinesterase is mainly in plasma and liver.

Deficiency of pseudocholinesterase, often due to inherited BCHE gene mutations, leads to increased sensitivity to choline ester muscle relaxants. Normally, neuromuscular function recovers within minutes after succinylcholine, but in affected individuals, paralysis and apnea may persist, requiring prolonged mechanical ventilation until drug clearance. Prevalence is estimated at 1 in 3,200–5,000 individuals. Acquired reductions occur in liver disease, malnutrition, chronic kidney disease, malignancy, and pregnancy. Conversely, elevated pseudocholinesterase activity is seen in obesity and chronic alcoholism.

Research also suggests a role in Alzheimer’s disease: increased plasma pseudocholinesterase may enhance the effect of ApoE4 in promoting cognitive decline, and higher enzyme levels have been associated with amyloid plaques and neurofibrillary tangles.

  • As an aid the diagnosis of pseudocholinesterase deficiency
  • Preoperative risk assessment before administration of succinylcholine or mivacurium
  • As an aid in the diagnosis and prognosis of Alzheimer’s disease

Increased in:

  • Alzheimer's disease with pathognomic features
  • Chronic alcoholism
  • Obesity

Decreased in:

  • Liver disease (acute and chronic)
  • Malnutrition and cachexia
  • Pregnancy and estrogen therapy (e.g., hormonal contraceptives)
  • Chronic kidney disease
  • Malignancy
Category Age Range / Condition Reference Range (U/L)
Male All ages 5,320 – 12,920
Female 0–15 years 5,320 – 12,920
  16–39 years 4,260 – 11,250
  40–41 years 5,320 – 12,920
  ≥42 years 5,320 – 12,920
  18–41 years (Pregnancy or hormonal contraceptive use) 3,650 – 9,120

 

Spectrophotometric assay measuring hydrolysis of butyrylthiocholine or other synthetic esters.

Serum, SST tube.

Stability

  • Ambient: 24 hours
  • Refrigerated: 5-7 days
  • Frozen: 60 days
Dibucaine inhibition test, fluoride inhibition test, genetic analysis of BCHE variants, liver function tests, nutritional markers (albumin, prealbumin).
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • AANA J. 2010 Aug;78(4):313-20. [PMID: 20879632]
  • Am J Med Sci. 2019 Mar;357(3):263-267. [PMID: 30578021]
  • Clin Chim Acta. 2015;450:34-45. [PMID: 25448037]
  • Benner A, Lewallen NF, Sadiq NM. Biochemistry, Pseudocholinesterase. [Updated 2022 Sep 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545284